Primary TSC2-Deficient Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model

    Clara Bernardelli, Eloisa Chiaramonte, Silvia Ancona, Silvia Maria Sirchia, A. Cerri, Elena Lesma
    Studysummary This study demonstrated that 5-azacytidine treatment may reduce TSC lesion-related hair follicles in mice, suggesting chromatin remodeling agents could be effective for tuberous sclerosis cutaneous lesions lacking tuberin.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study demonstrated that primary TSC2-/meth cells, which lack tuberin due to an epigenetic event, induced follicular neogenesis and cutaneous lesions in a TSC mouse model. These cells showed high mTOR activity and localized in hair bulbs, leading to skin thickening and hair growth. Treatment with 5-azacytidine reduced hair follicles and decreased mTOR activity, suggesting its potential effectiveness on TSC lesions. Additionally, TSC2-/meth cells exhibited metastatic capabilities, migrating to the lungs and causing tissue changes. This model provided insights into the role of mTOR in TSC-related skin and hair manifestations and highlighted the potential of targeting epigenetic silencing for treatment.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results